CG Oncology, Inc.

• CG Oncology (CGON) CCO Hire Puts Its Launch Valuation Narrative To The Test
  Simply Wall Street · 22 Oct 2026
• CG Oncology prepares to unveil data at NEAUA meeting: Can CGON break above $63.44?
  Traders Union · 20 Oct 2026
• CG Oncology's CCO Isabel Kalofonos Awarded 92,000 Stock Options on October 15, 2026
  Kalkine Media · 19 Oct 2026
• A director sells 1,000 CG Oncology (CGON) shares and exercises options at $0.60.
  Stock Titan · 19 Oct 2026
• [Form 3] CG Oncology, Inc. Initial Statement of Beneficial Ownership
  Stock Titan · 19 Oct 2026
• Form 144 CG Oncology For: 15 October By Investing.com
  Investing.com Nigeria · 16 Oct 2026
• A director plans to sell 3,000 shares of CG Oncology (NASDAQ: CGON).
  Stock Titan · 15 Oct 2026
• CG Oncology (CGON) Names New Commercial Chief As Valuation Turns Back To Cretostimogene
  Simply Wall Street · 14 Oct 2026
• CG Oncology appoints Isabel Kalofonos as chief commercial officer By Investing.com
  Investing.com India · 13 Oct 2026
• CG Oncology Appoints Proven Biopharmaceutical Commercial Leader Isabel Kalofonos as Chief Commercial Officer
  The Manila Times · 13 Oct 2026
• Kuehn Law Encourages Investors of CG Oncology, Inc. to Contact Law Firm
  PR Newswire · 13 Oct 2026
• Investigation launched into CG Oncology officers for possible self-dealing harming shareholders
  Pluang · 12 Oct 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →